Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	F_ACTIN_CAPPING_A_1	CAPZA1 CAPZA2	9.90e-05	3	108	2	PS00748
Domain	F_ACTIN_CAPPING_A_2	CAPZA1 CAPZA2	9.90e-05	3	108	2	PS00749
Domain	F-actin_cap_A	CAPZA1 CAPZA2	9.90e-05	3	108	2	PF01267
Domain	CapZ_alpha	CAPZA1 CAPZA2	9.90e-05	3	108	2	IPR002189
Domain	F-actin_cap_asu_CS	CAPZA1 CAPZA2	9.90e-05	3	108	2	IPR017865
Domain	Bcl2-/adenovirus-E1B	PRUNE2 BNIP2	1.97e-04	4	108	2	IPR022181
Domain	BNIP2	PRUNE2 BNIP2	1.97e-04	4	108	2	PF12496
Domain	CRAL_TRIO	PRUNE2 BNIP2 SEC14L1	2.32e-04	21	108	3	PF00650
Domain	-	PRUNE2 BNIP2 SEC14L1	3.06e-04	23	108	3	3.40.525.10
Domain	Anaphylatoxin_comp_syst	C4A C4B	3.28e-04	5	108	2	IPR018081
Domain	Anaphylatoxn_comp_syst_dom	C4A C4B	3.28e-04	5	108	2	IPR001840
Domain	SEC14	PRUNE2 BNIP2 SEC14L1	3.94e-04	25	108	3	SM00516
Domain	CRAL_TRIO	PRUNE2 BNIP2 SEC14L1	4.97e-04	27	108	3	PS50191
Domain	CRAL-TRIO_dom	PRUNE2 BNIP2 SEC14L1	5.54e-04	28	108	3	IPR001251
Domain	USP_CS	CYLD USP43 USP2 USP51	5.78e-04	66	108	4	IPR018200
Domain	ANATO	C4A C4B	6.83e-04	7	108	2	SM00104
Domain	ANAPHYLATOXIN_2	C4A C4B	6.83e-04	7	108	2	PS01178
Domain	ANAPHYLATOXIN_1	C4A C4B	6.83e-04	7	108	2	PS01177
Domain	ANATO	C4A C4B	6.83e-04	7	108	2	PF01821
Domain	Anaphylatoxin/fibulin	C4A C4B	6.83e-04	7	108	2	IPR000020
Domain	USP_1	CYLD USP43 USP2 USP51	7.23e-04	70	108	4	PS00972
Domain	RA	MYO9A MYO9B RGL3	7.51e-04	31	108	3	SM00314
Domain	UCH	CYLD USP43 USP2 USP51	7.63e-04	71	108	4	PF00443
Domain	USP_2	CYLD USP43 USP2 USP51	7.63e-04	71	108	4	PS00973
Domain	USP_3	CYLD USP43 USP2 USP51	8.04e-04	72	108	4	PS50235
Domain	USP_dom	CYLD USP43 USP2 USP51	8.04e-04	72	108	4	IPR028889
Domain	Peptidase_C19_UCH	CYLD USP43 USP2 USP51	8.04e-04	72	108	4	IPR001394
Domain	MacrogloblnA2_thiol-ester-bond	C4A C4B	9.07e-04	8	108	2	IPR019565
Domain	Thiol-ester_cl	C4A C4B	9.07e-04	8	108	2	PF10569
Domain	MacrogloblnA2_CS	C4A C4B	9.07e-04	8	108	2	IPR019742
Domain	RA	MYO9A MYO9B RGL3	1.17e-03	36	108	3	PF00788
Domain	P-loop_NTPase	MYO7A MYO9A MYO9B CFTR ABCC6 LONP1 CIITA ABCE1 DGUOK RECQL4 HS3ST3A1 DNAH8 NLRP8	1.22e-03	848	108	13	IPR027417
Domain	RA	MYO9A MYO9B RGL3	1.27e-03	37	108	3	PS50200
Domain	Myosin_head_motor_dom	MYO7A MYO9A MYO9B	1.37e-03	38	108	3	IPR001609
Domain	MYOSIN_MOTOR	MYO7A MYO9A MYO9B	1.37e-03	38	108	3	PS51456
Domain	Myosin_head	MYO7A MYO9A MYO9B	1.37e-03	38	108	3	PF00063
Domain	MYSc	MYO7A MYO9A MYO9B	1.37e-03	38	108	3	SM00242
Domain	A2M	C4A C4B	1.45e-03	10	108	2	PF00207
Domain	A2M_N_2	C4A C4B	1.45e-03	10	108	2	IPR011625
Domain	A2M_comp	C4A C4B	1.45e-03	10	108	2	IPR011626
Domain	A2M_recep	C4A C4B	1.45e-03	10	108	2	PF07677
Domain	A2M_comp	C4A C4B	1.45e-03	10	108	2	PF07678
Domain	A2M_N	C4A C4B	1.45e-03	10	108	2	PF01835
Domain	A2M_N	C4A C4B	1.45e-03	10	108	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	C4A C4B	1.45e-03	10	108	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	C4A C4B	1.45e-03	10	108	2	PS00477
Domain	A2M_N_2	C4A C4B	1.45e-03	10	108	2	PF07703
Domain	Macroglobln_a2	C4A C4B	1.45e-03	10	108	2	IPR001599
Domain	AAA	CFTR ABCC6 LONP1 ABCE1 DNAH8	1.50e-03	144	108	5	SM00382
Domain	AAA+_ATPase	CFTR ABCC6 LONP1 ABCE1 DNAH8	1.50e-03	144	108	5	IPR003593
Domain	RA_dom	MYO9A MYO9B RGL3	1.59e-03	40	108	3	IPR000159
Domain	ABC_transporter_CS	CFTR ABCC6 ABCE1	1.83e-03	42	108	3	IPR017871
Domain	TRYPSIN_SER	CTRB2 TMPRSS5 OVCH1 CTRB1	1.84e-03	90	108	4	IPR033116
Domain	-	MYO7A FRMPD2 DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	1.96e-03	391	108	8	2.30.29.30
Domain	CRAL_TRIO_2	PRUNE2 BNIP2	2.11e-03	12	108	2	PF13716
Domain	PH	DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	2.15e-03	229	108	6	PF00169
Domain	-	CAD SYN2	2.48e-03	13	108	2	3.40.50.20
Domain	ABC_tran	CFTR ABCC6 ABCE1	2.69e-03	48	108	3	PF00005
Domain	ABC_TRANSPORTER_2	CFTR ABCC6 ABCE1	2.69e-03	48	108	3	PS50893
Domain	ABC_TRANSPORTER_1	CFTR ABCC6 ABCE1	2.86e-03	49	108	3	PS00211
Domain	PreATP-grasp_dom	CAD SYN2	2.88e-03	14	108	2	IPR016185
Domain	TRYPSIN_HIS	CTRB2 TMPRSS5 OVCH1 CTRB1	3.01e-03	103	108	4	IPR018114
Domain	ABC_transporter-like	CFTR ABCC6 ABCE1	3.03e-03	50	108	3	IPR003439
Domain	-	CAD SYN2	3.31e-03	15	108	2	3.30.1490.20
Domain	PH_dom-like	MYO7A FRMPD2 DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	3.32e-03	426	108	8	IPR011993
Domain	TRYPSIN_SER	CTRB2 TMPRSS5 OVCH1 CTRB1	3.34e-03	106	108	4	PS00135
Domain	TRYPSIN_HIS	CTRB2 TMPRSS5 OVCH1 CTRB1	3.46e-03	107	108	4	PS00134
Domain	Peptidase_S1A	CTRB2 TMPRSS5 OVCH1 CTRB1	4.20e-03	113	108	4	IPR001314
Domain	Gal_mutarotase_SF_dom	MGAM MAN2C1	4.26e-03	17	108	2	IPR011013
Domain	C345C	C4A C4B	4.26e-03	17	108	2	SM00643
Domain	Ubiquitin-rel_dom	MYO7A MYO9A MYO9B RGL3 FRMPD2	4.33e-03	184	108	5	IPR029071
Domain	TRYPSIN_DOM	CTRB2 TMPRSS5 OVCH1 CTRB1	4.47e-03	115	108	4	PS50240
Domain	Tryp_SPc	CTRB2 TMPRSS5 OVCH1 CTRB1	4.75e-03	117	108	4	SM00020
Domain	ATP_grasp_subdomain_1	CAD SYN2	4.77e-03	18	108	2	IPR013815
Domain	Terpenoid_cyclase/PrenylTrfase	C4A C4B	4.77e-03	18	108	2	IPR008930
Domain	-	CAD SYN2	4.77e-03	18	108	2	3.30.470.20
Domain	HATPase_c	PMS1 PDK2	4.77e-03	18	108	2	SM00387
Domain	NTR	C4A C4B	5.31e-03	19	108	2	PF01759
Domain	Netrin_module_non-TIMP	C4A C4B	5.31e-03	19	108	2	IPR018933
Domain	HATPase_c	PMS1 PDK2	5.31e-03	19	108	2	PF02518
Domain	Trypsin_dom	CTRB2 TMPRSS5 OVCH1 CTRB1	5.35e-03	121	108	4	IPR001254
Domain	Trypsin	CTRB2 TMPRSS5 OVCH1 CTRB1	5.35e-03	121	108	4	PF00089
Domain	PH	DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	5.56e-03	278	108	6	SM00233
Domain	PH_DOMAIN	DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	5.66e-03	279	108	6	PS50003
Domain	Peptidase_S1_PA	CTRB2 TMPRSS5 OVCH1 CTRB1	5.67e-03	123	108	4	IPR009003
Domain	PH_domain	DOCK10 SYNGAP1 OSBPL5 NGEF PLCG2 CYTH4	5.76e-03	280	108	6	IPR001849
Pubmed	BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis.	MSX1 MSX2 BMP2	1.26e-07	4	111	3	20506112
Pubmed	Changes in homeobox-containing gene expression during ectopic bone formation induced by bone morphogenetic protein.	MSX1 MSX2 BMP2	1.26e-07	4	111	3	7911662
Pubmed	Comparison of expression of the msx-1, msx-2, BMP-2 and BMP-4 genes in the mouse upper diastemal and molar tooth primordia.	MSX1 MSX2 BMP2	1.26e-07	4	111	3	7577436
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PMS1 ACOT9 PKP4 DOCK10 UPF2 ABCE1 RECQL4 RBM14 XRN1 DIAPH2 C4A C4B SLC33A1	1.69e-07	650	111	13	38777146
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	CAD MYO9A MYO9B PKP4 UBR4 CAPZA1 CAPZA2 DOCK10 GTF3C5 LONP1 UPF2 ABCE1 RECQL4 RBM14 XRN1 PRKDC PLCG2 NIPBL	2.87e-07	1353	111	18	29467282
Pubmed	Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development.	MSX1 MSX2 BMP2	6.28e-07	6	111	3	8104708
Pubmed	Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development.	MSX1 MSX2 BMP2	6.28e-07	6	111	3	8787747
Pubmed	Msx2 -/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis.	MSX1 MSX2 BMP2	6.28e-07	6	111	3	17878071
Pubmed	Tails of unconventional myosins.	MYO7A MYO9A MYO9B	1.10e-06	7	111	3	11212352
Pubmed	Molecular mechanisms of cell and tissue interactions during early tooth development.	MSX1 MSX2 BMP2	1.10e-06	7	111	3	8769660
Pubmed	Association of developmental regulatory genes with the development of different molar tooth shapes in two species of rodents.	MSX1 MSX2 BMP2	1.75e-06	8	111	3	9799429
Pubmed	CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1.	CYLD MGAM CAD UBR4 CAPZA1 CAPZA2 KLHL13	2.06e-06	182	111	7	31067453
Pubmed	FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development.	MSX1 MSX2 BMP2	2.62e-06	9	111	3	9477322
Pubmed	Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head.	MSX1 MSX2 BMP2	2.62e-06	9	111	3	20398647
Pubmed	Bmp2, Bmp4 and Bmp7 are co-required in the mouse AER for normal digit patterning but not limb outgrowth.	MSX1 MSX2 BMP2	2.62e-06	9	111	3	22662233
Pubmed	BMP-mediated functional cooperation between Dlx5;Dlx6 and Msx1;Msx2 during mammalian limb development.	MSX1 MSX2 BMP2	2.62e-06	9	111	3	23382810
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CAD MYO7A MYO9A PKP4 CAPZA1 CAPZA2 SYNGAP1 LONP1 UPF2 STON2 NGEF RBM14 XRN1 SYN2 C4A C4B SSH2	2.96e-06	1431	111	17	37142655
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	CAD RGS7BP MYO9A MYO9B PKP4 UBR4 CAPZA1 CAPZA2 ABCE1 RBM14 C4A C4B PRKDC	3.11e-06	844	111	13	25963833
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	MYO9A MYO9B GHSR BMP2 SOCS5 FGFR4 L3MBTL3	3.59e-06	198	111	7	20881960
Pubmed	Coordinate regulation and synergistic actions of BMP4, SHH and FGF8 in the rostral prosencephalon regulate morphogenesis of the telencephalic and optic vesicles.	MSX1 MSX2 BMP2	3.74e-06	10	111	3	11955708
Pubmed	Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin.	CYLD PARP11 USP43 USP2	3.74e-06	33	111	4	30323974
Pubmed	BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling.	MSX1 MSX2 BMP2	5.12e-06	11	111	3	17537800
Pubmed	Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4.	MSX1 MSX2 BMP2	5.12e-06	11	111	3	14512019
Pubmed	Cdc42 is required for chondrogenesis and interdigital programmed cell death during limb development.	MSX1 MSX2 BMP2	6.82e-06	12	111	3	22387309
Pubmed	Analysis of Msx1; Msx2 double mutants reveals multiple roles for Msx genes in limb development.	MSX1 MSX2 BMP2	8.84e-06	13	111	3	15930102
Pubmed	Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice.	EPO CTRB2 SLC9A2 CTRB1	9.08e-06	41	111	4	23676500
Pubmed	Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.	C4A C4B	1.01e-05	2	111	2	22737222
Pubmed	Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.	C4A C4B	1.01e-05	2	111	2	16565498
Pubmed	Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.	C4A C4B	1.01e-05	2	111	2	15998580
Pubmed	Insertional mutation of the mouse Msx1 homeobox gene by an nlacZ reporter gene.	MSX1 MSX2	1.01e-05	2	111	2	9256350
Pubmed	High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.	C4A C4B	1.01e-05	2	111	2	19062096
Pubmed	Clcn2 encodes the hyperpolarization-activated chloride channel in the ducts of mouse salivary glands.	CFTR CLCN2	1.01e-05	2	111	2	18801913
Pubmed	Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.	C4A C4B	1.01e-05	2	111	2	19933335
Pubmed	Msx1 and Msx2 gene expression is downregulated in the cadmium-induced omphalocele in the chick model.	MSX1 MSX2	1.01e-05	2	111	2	20620318
Pubmed	Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.	C4A C4B	1.01e-05	2	111	2	2459207
Pubmed	Antigen-induced B cell apoptosis is independent of complement C4.	C4A C4B	1.01e-05	2	111	2	17645767
Pubmed	Anti-DNA autoreactivity in C4-deficient mice.	C4A C4B	1.01e-05	2	111	2	12207352
Pubmed	MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.	CIITA PRKDC	1.01e-05	2	111	2	16081800
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	1.01e-05	2	111	2	28951524
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	1.01e-05	2	111	2	28754779
Pubmed	Ventral abdominal wall dysmorphogenesis of Msx1/Msx2 double-mutant mice.	MSX1 MSX2	1.01e-05	2	111	2	15803476
Pubmed	Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.	C4A C4B	1.01e-05	2	111	2	27758680
Pubmed	Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.	C4A C4B	1.01e-05	2	111	2	22387014
Pubmed	Cloning of ClC-2 chloride channel from murine duodenum and its presence in CFTR knockout mice.	CFTR CLCN2	1.01e-05	2	111	2	10524221
Pubmed	MHC class II-restricted interaction between thymocytes plays an essential role in the production of innate CD8+ T cells.	CD1D CIITA	1.01e-05	2	111	2	21478404
Pubmed	Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor.	CAD ALK	1.01e-05	2	111	2	28368455
Pubmed	Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.	C4A C4B	1.01e-05	2	111	2	23749435
Pubmed	Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.	C4A C4B	1.01e-05	2	111	2	23918728
Pubmed	Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.	C4A C4B	1.01e-05	2	111	2	3037333
Pubmed	Ectoderm-mesenchyme and mesenchyme-mesenchyme interactions regulate Msx-1 expression and cellular differentiation in the murine limb bud.	MSX1 MSX2	1.01e-05	2	111	2	7537232
Pubmed	Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.	C4A C4B	1.01e-05	2	111	2	11726230
Pubmed	Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.	C4A C4B	1.01e-05	2	111	2	4216347
Pubmed	Sequence determination of the thiolester site of the fourth component of human complement.	C4A C4B	1.01e-05	2	111	2	6950384
Pubmed	Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.	C4A C4B	1.01e-05	2	111	2	8660986
Pubmed	Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.	C4A C4B	1.01e-05	2	111	2	8428773
Pubmed	Comparison of MSX-1 and MSX-2 suggests a molecular basis for functional redundancy.	MSX1 MSX2	1.01e-05	2	111	2	8861098
Pubmed	Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions.	MSX1 MSX2	1.01e-05	2	111	2	8660900
Pubmed	Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.	C4A C4B	1.01e-05	2	111	2	24638111
Pubmed	MHC class II-expressing thymocytes suppress invariant NKT cell development.	CD1D CIITA	1.01e-05	2	111	2	18982019
Pubmed	Transcriptional repression of C4 complement by hepatitis C virus proteins.	C4A C4B	1.01e-05	2	111	2	21345967
Pubmed	Cleavage of BNIP-2 and BNIP-XL by caspases.	PRUNE2 BNIP2	1.01e-05	2	111	2	17961507
Pubmed	Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models.	CFTR CLCN2	1.01e-05	2	111	2	15007059
Pubmed	Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.	C4A C4B	1.01e-05	2	111	2	2572548
Pubmed	The complement component C4 of mammals.	C4A C4B	1.01e-05	2	111	2	2302180
Pubmed	Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.	C4A C4B	1.01e-05	2	111	2	22151770
Pubmed	C4d-positive chronic rejection: a frequent entity with a poor outcome.	C4A C4B	1.01e-05	2	111	2	18091514
Pubmed	Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.	C4A C4B	1.01e-05	2	111	2	29080553
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	1.01e-05	2	111	2	2917002
Pubmed	Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.	C4A C4B	1.01e-05	2	111	2	6589636
Pubmed	Epithelial-mesenchymal interactions are required for msx 1 and msx 2 gene expression in the developing murine molar tooth.	MSX1 MSX2	1.01e-05	2	111	2	8101167
Pubmed	C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.	C4A C4B	1.01e-05	2	111	2	25339671
Pubmed	A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.	C4A C4B	1.01e-05	2	111	2	17728371
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	1.01e-05	2	111	2	8186414
Pubmed	Structure and organization of the C4 genes.	C4A C4B	1.01e-05	2	111	2	6149580
Pubmed	Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.	C4A C4B	1.01e-05	2	111	2	6149581
Pubmed	The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.	C4A C4B	1.01e-05	2	111	2	12115608
Pubmed	Biochemistry and biology of anaphylatoxins.	C4A C4B	1.01e-05	2	111	2	3542363
Pubmed	Msx homeobox gene family and craniofacial development.	MSX1 MSX2	1.01e-05	2	111	2	14728799
Pubmed	C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.	C4A C4B	1.01e-05	2	111	2	2387317
Pubmed	Identification of the size and antigenic determinants of the human C4 gene by a polymerase chain-reaction-based amplification method.	C4A C4B	1.01e-05	2	111	2	16908004
Pubmed	Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.	C4A C4B	1.01e-05	2	111	2	7365238
Pubmed	Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.	C4A C4B	1.01e-05	2	111	2	7391573
Pubmed	Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.	C4A C4B	1.01e-05	2	111	2	17971360
Pubmed	Clinical features of patients with homozygous complement C4A or C4B deficiency.	C4A C4B	1.01e-05	2	111	2	29928053
Pubmed	Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.	C4A C4B	1.01e-05	2	111	2	17971229
Pubmed	Msh homeobox 1 (Msx1)- and Msx2-overexpressing bone marrow-derived mesenchymal stem cells resemble blastema cells and enhance regeneration in mice.	MSX1 MSX2	1.01e-05	2	111	2	28461333
Pubmed	Genetic deficiency of C4 presenting with recurrent infections and a SLE-like disease. Genetic and immunologic studies.	C4A C4B	1.01e-05	2	111	2	6881182
Pubmed	[Induction phenomena during vertebrate limb development and homeo box gene expression].	MSX1 MSX2	1.01e-05	2	111	2	8099267
Pubmed	Partial C4 deficiency in juvenile idiopathic arthritis patients.	C4A C4B	1.01e-05	2	111	2	17921792
Pubmed	Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.	C4A C4B	1.01e-05	2	111	2	21880985
Pubmed	Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.	C4A C4B	1.01e-05	2	111	2	6978711
Pubmed	Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.	C4A C4B	1.01e-05	2	111	2	35898513
Pubmed	Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.	CFTR CLCN2	1.01e-05	2	111	2	18805957
Pubmed	Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.	C4A C4B	1.01e-05	2	111	2	28873507
Pubmed	Generation of an Msx2-GFP conditional null allele.	MSX1 MSX2	1.01e-05	2	111	2	18442049
Pubmed	Studies on the murine Ss protein: demonstration that the Ss protein is functionally the fourth component of complement.	C4A C4B	1.01e-05	2	111	2	276882
Pubmed	Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.	C4A C4B	1.01e-05	2	111	2	6832377
Pubmed	Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.	C4A C4B	1.01e-05	2	111	2	3794341
Pubmed	Loss of homeoprotein Msx1 and Msx2 leading to athletic and kinematic impairment related to the increasing neural excitability of neurons in aberrant neocortex in mice.	MSX1 MSX2	1.01e-05	2	111	2	31221479
Pubmed	Position-dependent expression of two related homeobox genes in developing vertebrate limbs.	MSX1 MSX2	1.01e-05	2	111	2	1677742
Interaction	VIM interactions	CYLD CAD CFTR UBR4 DOCK10 CC2D1A SYNGAP1 KIAA1671 MSX2 PNMA5 CLCN2 ABCE1 RECQL4 PRKDC ALK FAM118B	5.84e-06	804	108	16	int:VIM
GeneFamily	Myosins, class IX	MYO9A MYO9B	1.93e-05	2	80	2	1103
GeneFamily	Ubiquitin specific peptidases	CYLD USP43 USP2 USP51	1.10e-04	56	80	4	366
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	PRUNE2 BNIP2	4.00e-04	7	80	2	1299
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	C4A C4B	6.82e-04	9	80	2	1234
GeneFamily	ATP binding cassette subfamily C	CFTR ABCC6	1.46e-03	13	80	2	807
GeneFamily	Olfactory receptors, family 13	OR13C6P OR13C7	4.61e-03	23	80	2	162
GeneFamily	PHD finger proteins\|Lysine demethylases	PHF2 KDM7A	5.01e-03	24	80	2	485
GeneFamily	NLR family	CIITA NLRP8	5.43e-03	25	80	2	666
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFAP47 FRMPD2 MSX1 MSX2 STON2 DISP3 HS3ST3A1	3.81e-07	184	110	7	22c18964818fc9c8f18051f836d718937b0d8d12
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	OPN1SW KLHL13 C4B CTRB1 HS3ST3A1	3.31e-06	92	110	5	84ac97a16920b912a67ea80e71146eddf9dfa92f
ToppCell	Ionocyte-iono-1\|World / Class top	CFTR ABCC6 MSX2 BMP2 SYN2 PLCG2	3.98e-06	169	110	6	4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell	Ionocyte\|World / Class top	CFTR ABCC6 MSX2 BMP2 SYN2 PLCG2	4.12e-06	170	110	6	d2e592f2a679e6a8d32f2b752d9a3c493e50ced4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFAP47 CTRB2 CD1D KLHL13 STON2 ALK	5.20e-06	177	110	6	5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b
ToppCell	droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 RGS7BP WDR25 MSX1 BMP2 KLHL13	5.54e-06	179	110	6	b7281160c84dd053a2981c9c76ea6cc6d2592cd5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFAP47 RGL3 MSX1 MSX2 STON2 HS3ST3A1	7.12e-06	187	110	6	2b1b2c3792d6c9ab69675ce88842bb589414b530
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO9B ACOT9 PPARD CD1D CIITA CYTH4	7.80e-06	190	110	6	ad297172a74a80ed5c10f921e15efd1da0fd2d6b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B ARRDC5 DOCK10 CIITA MS4A14 CYTH4	8.03e-06	191	110	6	baa70781633a3fe5bf987f9d8dff3884f5167e7f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CFAP47 CFTR TMPRSS5 CLCN2 MS4A14	4.03e-05	154	110	5	ce4b1e878cd88065fbfd2df18caf19703fec37d8
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PHEX PROM2 MS4A14 HS3ST3A1 DNAH8	4.03e-05	154	110	5	9200e2f1783e54cbc5dfc3b485b57c761af74a46
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CFTR HCN3 KLHL13 DISP3 ALK	4.70e-05	159	110	5	7f29f9dcf25ffa1822b137c571e9ac16defc6292
ToppCell	droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 BMP2 CIITA C4A HS3ST3A1	4.98e-05	161	110	5	f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9
ToppCell	droplet-Lung-nan-3m-Myeloid-lung_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 BMP2 CIITA C4A HS3ST3A1	4.98e-05	161	110	5	110cc7122e3c9f105a11d811d77c8a8852b9de6c
ToppCell	facs-MAT-Fat-3m-Myeloid-macrophage\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK10 CIITA PLCG2 LTB4R CYTH4	5.44e-05	164	110	5	b81498c3934e0d52bf0329dc745e02966f9d8613
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ZFYVE16 CIITA LTB4R CYTH4	5.93e-05	167	110	5	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CFAP47 RGL3 MSX1 MSX2 STON2	6.82e-05	172	110	5	55fba5ce0ead1114e1a76f67ad68432c6bac90e5
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A DUSP1 DOCK10 KDM7A SSH2	7.01e-05	173	110	5	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	Ionocyte-iono-2\|World / Class top	CFTR CPT2 BMP2 SYN2 PLCG2	7.01e-05	173	110	5	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A DUSP1 DOCK10 KDM7A SSH2	7.01e-05	173	110	5	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A DUSP1 DOCK10 KDM7A SSH2	7.01e-05	173	110	5	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	facs-Lung-EPCAM-18m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK10 CIITA PROM2 LTB4R CYTH4	7.81e-05	177	110	5	7bc92314b22a876296a4e2db51e7fb0fdfd69379
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRUNE2 PPARD SLC9A2 KDM7A ALK	8.23e-05	179	110	5	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DACT2 ABCC6 CLCN2 C4B FGFR4	9.13e-05	183	110	5	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP1 DOCK10 XRN1 DIAPH2 NIPBL	9.61e-05	185	110	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARRDC5 DOCK10 CIITA MS4A14 CYTH4	9.86e-05	186	110	5	e152bdd837366e3e0b8bcfdb4d53f0685f2e803a
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SLC4A7 MYO9A PKP4 USP43	1.01e-04	187	110	5	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PARP11 MSX1 CLCN2 XRN1 DISP3	1.01e-04	187	110	5	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO7A CIITA STON2 MS4A14 CYTH4	1.01e-04	187	110	5	39b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 MYO9A XRN1 KDM7A SEC14L1	1.04e-04	188	110	5	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 MYO9A XRN1 KDM7A SEC14L1	1.04e-04	188	110	5	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCDHGB5 MYO9A XRN1 KDM7A SEC14L1	1.04e-04	188	110	5	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 SLC4A7 MYO9A PKP4 USP43	1.04e-04	188	110	5	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CFAP47 RGL3 CFTR USP43 ABCC6	1.06e-04	189	110	5	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM SLC4A7 DUSP1 USP2 SEC14L1	1.06e-04	189	110	5	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B ARRDC5 CIITA MS4A14 CYTH4	1.09e-04	190	110	5	788ff9d8888d2dd25b7e1d7e0e5d57751ce86f19
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARRDC5 DOCK10 CIITA MS4A14 CYTH4	1.12e-04	191	110	5	c72e62cf5b45c04ee5e7719db31f917c4f76b1e4
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARRDC5 DOCK10 CIITA MS4A14 CYTH4	1.17e-04	193	110	5	f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZFYVE16 MYO9B PPARD CIITA CYTH4	1.20e-04	194	110	5	3043f6230fa723037c8cf7123f611ae847b39fd4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARRDC5 DOCK10 CIITA MS4A14 CYTH4	1.26e-04	196	110	5	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	Children_(3_yrs)-Immune-monocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DOCK10 CD1D CIITA KDM7A CYTH4	1.26e-04	196	110	5	cacd69be72e6167814f7adea7c5fa114f3103bbb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK10 CD1D CIITA MS4A14 CYTH4	1.26e-04	196	110	5	291c59b609985167c98a40d4e2caeea2fad74941
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	CYLD ZNF469 CIITA STON2 CYTH4	1.26e-04	196	110	5	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.29e-04	197	110	5	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	MGAM MYO9B DOCK10 SSH2 CYTH4	1.29e-04	197	110	5	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.29e-04	197	110	5	d95565652ca318a2298d6918d54ba6367e9560f4
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.29e-04	197	110	5	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9B DOCK10 OVCH1 CIITA MS4A14	1.32e-04	198	110	5	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.32e-04	198	110	5	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DUSP1 CD1D DIAPH2 MS4A14 FGFR4	1.32e-04	198	110	5	a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9B DOCK10 OVCH1 CIITA MS4A14	1.32e-04	198	110	5	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	MYO9B DOCK10 PPARD CIITA CYTH4	1.32e-04	198	110	5	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MGAM MYO7A DOCK10 CIITA RECQL4	1.32e-04	198	110	5	732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HCN3 KCNB2 KIAA1671 C3orf33 USP51	1.32e-04	198	110	5	d6812494874be0c14361ac2ac3e418b335bb8f55
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.35e-04	199	110	5	04adf46975aa4194ea40c7480f8a517def5d929c
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARRDC5 DOCK10 CIITA MS4A14 CYTH4	1.35e-04	199	110	5	744b63fba33b176ab7dde11646ccb313665505f7
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9B DOCK10 CIITA MS4A14 CYTH4	1.35e-04	199	110	5	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RGS7BP PKP4 DIAPH2 NIPBL SEC14L1	1.38e-04	200	110	5	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Macroglial-Astrocytes-GFAP---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 FRMPD2 MSX1 MSX2 HS3ST3A1	1.38e-04	200	110	5	88d66550781a3c9102ff7455f5cff6fb072943cd
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7A MYO9B CIITA MS4A14 CYTH4	1.38e-04	200	110	5	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	Macroglial-Astrocytes-GFAP-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 FRMPD2 MSX1 MSX2 HS3ST3A1	1.38e-04	200	110	5	d6a059b0ef763c281c60b1ac76da6079ea822f80
ToppCell	Macroglial-Astrocytes-GFAP--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 FRMPD2 MSX1 MSX2 HS3ST3A1	1.38e-04	200	110	5	16269fa4adb28fc6ed032bbdba8781237dd0d249
ToppCell	Macroglial-Astrocytes-GFAP----L1-2\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 FRMPD2 MSX1 MSX2 HS3ST3A1	1.38e-04	200	110	5	c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 SLC4A7 KLHL13 DIAPH2 HS3ST3A1	1.38e-04	200	110	5	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Macroglial-Astrocytes-GFAP\|Macroglial / cells hierarchy compared to all cells using T-Statistic	CFAP47 FRMPD2 MSX1 MSX2 HS3ST3A1	1.38e-04	200	110	5	79634b1086934412ae92f259ab43554ce545008f
Drug	H2DIDS	SLC4A7 CFTR CTRB2 SLC9A2 DIAPH2 CTRB1	1.04e-08	33	109	6	CID000115184
Drug	Sri 8835	MGAM CTRB2 CTRB1	2.11e-06	6	109	3	CID000479975
Drug	AcPheOEt	CFTR CTRB2 CTRB1	5.87e-06	8	109	3	CID000094229
Drug	isobutyllithium	MGAM ABCE1 SOCS5	1.25e-05	10	109	3	CID000141200
Drug	BOCPheONP	CTRB2 CTRB1	2.27e-05	2	109	2	CID000111308
Drug	MPM-06	CTRB2 CTRB1	2.27e-05	2	109	2	CID000161546
Drug	NSC-374899	CTRB2 CTRB1	2.27e-05	2	109	2	CID000435726
Drug	methylbenzenebutanoate	CTRB2 CTRB1	2.27e-05	2	109	2	CID000281254
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	2.27e-05	2	109	2	CID004418081
Drug	c189	CTRB2 CTRB1	2.27e-05	2	109	2	CID000248048
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	2.27e-05	2	109	2	CID000191369
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	2.27e-05	2	109	2	CID011820300
Drug	4,4'-diaminostilbene	CFTR CLCN2	2.27e-05	2	109	2	CID000092134
Drug	5-aminotetrazole	CTRB2 CTRB1	2.27e-05	2	109	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	2.27e-05	2	109	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	2.27e-05	2	109	2	CID000122753
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	2.27e-05	2	109	2	CID000191275
Drug	isobutyl sulfide	CTRB2 CTRB1	2.27e-05	2	109	2	CID000011607
Drug	naphthol-AS-BI	MGAM MAN2C1 CTRB2 CTRB1	2.91e-05	37	109	4	CID000071060
Drug	Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A	PRUNE2 PARP11 MYO9B DUSP1 PPARD SLC9A2 FGFR4	3.92e-05	192	109	7	4303_UP
Drug	Metaraminol bitartrate [33402-03-8]; Up 200; 8.6uM; PC3; HT_HG-U133A	DUSP1 HLCS PPARD PHEX BMP2 SYN2 FGFR4	4.33e-05	195	109	7	3669_UP
Drug	Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	PDK2 HLCS WDR25 MSX1 CLCN2 FGFR4 HS3ST3A1	4.47e-05	196	109	7	5022_DN
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; HL60; HT_HG-U133A	ZFYVE16 PDK2 CFTR UBR4 HLCS WDR25 DIAPH2	4.77e-05	198	109	7	2165_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; HL60; HT_HG-U133A	HLCS CTRB2 LBP CIITA DIAPH2 SYN2 LTB4R	4.92e-05	199	109	7	2187_UP
Drug	AC1L1GEZ	EPO RGL3 CFTR CTRB2 PHEX ABCE1 CTRB1	5.08e-05	200	109	7	CID000003653
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	6.79e-05	3	109	2	CID000087784
Drug	photophor	CTRB2 CTRB1	6.79e-05	3	109	2	CID000014780
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	6.79e-05	3	109	2	CID004309911
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000171547
Drug	potassium phosphate	MSX2 BMP2	6.79e-05	3	109	2	ctd:C013216
Drug	AFMeq	CTRB2 CTRB1	6.79e-05	3	109	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	6.79e-05	3	109	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	6.79e-05	3	109	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	6.79e-05	3	109	2	CID000152933
Drug	c140	CTRB2 CTRB1	6.79e-05	3	109	2	CID002783250
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	6.79e-05	3	109	2	CID000127677
Drug	2-aminothiophenol	C4A C4B	6.79e-05	3	109	2	ctd:C005464
Drug	phenyl hippurate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	6.79e-05	3	109	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	6.79e-05	3	109	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	6.79e-05	3	109	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	6.79e-05	3	109	2	CID000328214
Drug	C18 4	CTRB2 CTRB1	6.79e-05	3	109	2	CID000077248
Drug	taraxastane	CTRB2 CTRB1	6.79e-05	3	109	2	CID006429404
Drug	Phe-phe-ome	CTRB2 CTRB1	6.79e-05	3	109	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	6.79e-05	3	109	2	CID000065389
Drug	3-amino-2-pyridone	CTRB2 CTRB1	6.79e-05	3	109	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	6.79e-05	3	109	2	CID003035649
Drug	calcium carbonate phosphate	MGAM OPN1SW	6.79e-05	3	109	2	CID006337635
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000070396
Drug	Z-Phe-OMe	CTRB2 CTRB1	6.79e-05	3	109	2	CID003082435
Drug	3-methylcoumarin	CTRB2 CTRB1	6.79e-05	3	109	2	CID000017130
Drug	P 1 21 1	CYLD DIAPH2	6.79e-05	3	109	2	CID000018450
Drug	2-propyl methylphosphonochloridate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000102124
Drug	FK-316	CTRB2 CTRB1	6.79e-05	3	109	2	CID000133688
Drug	AC1L19T8	CTRB2 CTRB1	6.79e-05	3	109	2	CID000000694
Drug	Marinostatin D	CTRB2 CTRB1	6.79e-05	3	109	2	CID000132206
Drug	N(3)ATP	MGAM CFTR	6.79e-05	3	109	2	CID000133414
Drug	1FD7	CTRB2 CTRB1	6.79e-05	3	109	2	CID000445579
Drug	Glt-leu-phe-nh-meq	CTRB2 CTRB1	6.79e-05	3	109	2	CID000194914
Drug	AC1L4Z4F	CTRB2 CTRB1	6.79e-05	3	109	2	CID000194913
Drug	Glt-Phe-NH-FMeq	CTRB2 CTRB1	6.79e-05	3	109	2	CID000194912
Drug	diacetyl trimer	CTRB2 CTRB1	6.79e-05	3	109	2	CID000193527
Drug	FK-448	CTRB2 CTRB1	6.79e-05	3	109	2	CID006917869
Drug	Ac-Phe-OMe	CTRB2 CTRB1	6.79e-05	3	109	2	CID000097805
Drug	thiobenzyl N-heptafluorobutyrylanthranilate	CTRB2 CTRB1	6.79e-05	3	109	2	CID000133906
Drug	DMPX	CFTR GHSR MSX2 LTB4R	8.22e-05	48	109	4	CID000099562
Drug	alizarin red S	CFTR OPN1SW ABCC6 MSX2 BMP2	9.43e-05	95	109	5	CID000008534
Drug	ppcA	MGAM MAN2C1 SLC33A1	9.78e-05	19	109	3	CID000125885
Drug	phenylmethyl	RGL3 CTRB2 LTB4R CTRB1	1.21e-04	53	109	4	CID000123147
Drug	Benzoyl-dl-leucine	CTRB2 CTRB1	1.35e-04	4	109	2	CID000294887
Drug	Acafcek	CTRB2 CTRB1	1.35e-04	4	109	2	CID000197677
Drug	B-1,3-od	CTRB2 CTRB1	1.35e-04	4	109	2	CID011971053
Drug	dehydromerodesmosine	CTRB2 CTRB1	1.35e-04	4	109	2	CID006443540
Drug	alpha-amyrin palmitate	CTRB2 CTRB1	1.35e-04	4	109	2	CID000185477
Drug	poly-THIQ	CTRB2 CTRB1	1.35e-04	4	109	2	CID006453487
Drug	N-(4-carboxycyclohexylmethyl)-maleimide	CTRB2 CTRB1	1.35e-04	4	109	2	CID011548799
Drug	G2505_sigma	CTRB2 CTRB1	1.35e-04	4	109	2	CID000111098
Drug	p-fluorobenzenesulfonyl chloride	CTRB2 CTRB1	1.35e-04	4	109	2	CID000009588
Drug	BSSDA	CTRB2 CTRB1	1.35e-04	4	109	2	CID003081106
Drug	biotinamidocaproyl hydrazide	EPO RGL3	1.35e-04	4	109	2	CID000083900
Drug	AC1L2HV6	CTRB2 CTRB1	1.35e-04	4	109	2	CID000047328
Drug	AC1L4X1Z	CTRB2 CTRB1	1.35e-04	4	109	2	CID000193815
Drug	NSC-676827	CTRB2 CTRB1	1.35e-04	4	109	2	CID000385555
Drug	6-amino-1,2-benzopyrone	CTRB2 CTRB1	1.35e-04	4	109	2	CID000046152
Drug	nitrophenylethanol	CTRB2 CTRB1	1.35e-04	4	109	2	CID000097851
Drug	A0666_sigma	SLC4A7 RGL3 SLC9A2 SYN2	1.51e-04	56	109	4	CID000005680
Drug	bicarbonate	MGAM CAD SLC4A7 CFTR CTRB2 OPN1SW SLC9A2 CTRB1	1.72e-04	325	109	8	CID000000767
Drug	Ac-Trp-OEt	CTRB2 CTRB1	2.25e-04	5	109	2	CID000304749
Drug	Icsl	CFTR C4A	2.25e-04	5	109	2	CID000172743
Drug	3-Cppap	ABCC6 PHEX	2.25e-04	5	109	2	CID000194170
Drug	apne	CTRB2 CTRB1	2.25e-04	5	109	2	CID000098192
Drug	calcium nitrate tetrahydrate	MGAM CFTR	2.25e-04	5	109	2	CID000026061
Drug	7-chloro-4-nitrobenzofuran	CTRB2 CTRB1	2.25e-04	5	109	2	CID000130782
Drug	Z-Phe-Leu	CTRB2 CTRB1	2.25e-04	5	109	2	CID000333351
Drug	5'-FSBAzA	CTRB2 CTRB1	2.25e-04	5	109	2	CID000130430
Drug	AC1L3F57	CTRB2 CTRB1	2.25e-04	5	109	2	CID000139565
Drug	3,5-dimethylpyrazole-1-carboxamidine	CTRB2 CTRB1	2.25e-04	5	109	2	CID000097525
Drug	Maap-borov	CTRB2 CTRB1	2.25e-04	5	109	2	CID005486914
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	1.30e-05	2	107	2	OBA_2041192
Disease	mean arterial pressure	SLC4A7 RGS7BP PCNX3 MYO9B RGL3 PKP4 CAPZA1 DOCK10 HLCS PPARD	1.42e-05	499	107	10	EFO_0006340
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	3.90e-05	3	107	2	EFO_0801477
Disease	Colorectal Carcinoma	CAD CFTR FRMPD2 KCNB2 ABCC6 BMP2 ABCE1 DNAH8 SLC33A1 ANAPC4 NLRP8	5.00e-05	702	107	11	C0009402
Disease	mitochondrial heteroplasmy measurement	MGAM BMP2 LONP1 DGUOK	1.18e-04	69	107	4	EFO_0600008
Disease	systemic lupus erythematosus	PCNX3 DOCK10 PPARD CPT2 OPN1SW SYNGAP1 PRR14 CIITA SYN2 C4B L3MBTL3	1.57e-04	799	107	11	MONDO_0007915
Disease	syndromic X-linked intellectual disability (implicated_via_orthology)	PHF2 KDM7A	3.60e-04	8	107	2	DOID:0060309 (implicated_via_orthology)
Disease	pancreatitis (biomarker_via_orthology)	DUSP1 CTRB2 CTRB1	3.85e-04	39	107	3	DOID:4989 (biomarker_via_orthology)
Disease	cystic fibrosis (implicated_via_orthology)	CFTR CLCN2	4.61e-04	9	107	2	DOID:1485 (implicated_via_orthology)
Disease	spleen volume	MYO9B SYN2 L3MBTL3	5.15e-04	43	107	3	EFO_0600047
Disease	tooth agenesis (is_implicated_in)	MSX1 BMP2	5.75e-04	10	107	2	DOID:0050591 (is_implicated_in)
Disease	trypsin-2 measurement	CTRB2 CTRB1	7.01e-04	11	107	2	EFO_0008305
Disease	developmental disorder of mental health (implicated_via_orthology)	CAPZA1 CAPZA2 SYNGAP1	7.57e-04	49	107	3	DOID:0060037 (implicated_via_orthology)
Disease	Cooley's anemia	EPO CAD	8.40e-04	12	107	2	C0002875
Disease	Thalassemia Intermedia	EPO CAD	8.40e-04	12	107	2	C0271979
Disease	Thalassemia Minor	EPO CAD	8.40e-04	12	107	2	C0085578
Disease	beta Thalassemia	EPO CAD	8.40e-04	12	107	2	C0005283
Disease	Rhabdomyosarcoma	FGFR4 ALK	1.33e-03	15	107	2	C0035412
Disease	Hemoglobin F Disease	EPO CAD	1.33e-03	15	107	2	C0019025
Disease	systemic lupus erythematosus (is_implicated_in)	CIITA C4A C4B	1.50e-03	62	107	3	DOID:9074 (is_implicated_in)
Disease	diet measurement	MGAM TMPRSS5 PHF2 ZNF469 STON2 NGEF PCDHGB4 PRKDC PLCG2 NIPBL ANAPC4	1.50e-03	1049	107	11	EFO_0008111
Disease	Uremia	EPO BMP2	1.71e-03	17	107	2	C0041948
Disease	Cardiomyopathies, Primary	EPO PDK2 PPARD	2.04e-03	69	107	3	C0033141
Disease	Myocardial Diseases, Secondary	EPO PDK2 PPARD	2.04e-03	69	107	3	C0036529
Disease	melanoma	EPO MYO7A UBR4 PPARD ALK	2.13e-03	248	107	5	C0025202
Disease	Lupus Erythematosus, Systemic	PCNX3 C4A C4B	2.22e-03	71	107	3	C0024141
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB5 OSBPL5 PCDHGB4	2.22e-03	71	107	3	EFO_0007878, EFO_0007979
Disease	Craniosynostosis	MSX2 BMP2	2.37e-03	20	107	2	C0010278
Disease	Craniofacial Abnormalities	PHEX MSX1 MSX2 NIPBL	2.54e-03	156	107	4	C0376634
Disease	progression free survival, ovarian serous carcinoma	MGAM MSX1	2.87e-03	22	107	2	EFO_0004920, EFO_1001516
Disease	hemoglobin A1 measurement	MGAM MYO9B CTRB2 SYN2 CTRB1 L3MBTL3 ANAPC4	2.91e-03	520	107	7	EFO_0007629
Disease	Alcoholic Intoxication, Chronic	CFTR GHSR STON2 OSBPL5 ALK	2.98e-03	268	107	5	C0001973

Protein segments in the cluster

Peptide	Gene	Start	Entry
FITPVSTLERDRFKS	PKP4	1011	Q99569
FLKAPQSFRAELSSI	SLC33A1	61	O00400
ITLLKLATPARFSQT	CTRB2	121	Q6GPI1
PSSFTRTRTSFLKAL	DISP3	1346	Q9P2K9
RSEDSTRRLFKFPFL	ANAPC4	561	Q9UJX5
LFRQAISPSDRVKLF	CFTR	1436	P13569
SSFFTLSLQKPRLLL	C4B	11	P0C0L5
QAFPKLVRILTAFSS	CIITA	971	P33076
SDTTFKALRRQLPVT	CAPZA1	251	P52907
VQKLSRFPLARQFSL	FGFR4	406	P22455
QTFSFLSRLKVQLEP	DGUOK	111	Q16854
LSTLDPKTISFRSRV	ACOT9	266	Q9Y305
LRNLFDSIKSEPFSI	CYTH4	231	Q9UIA0
QPRLSSILFKLTFEE	DIAPH2	791	O60879
TANSKFPVTRLLDTR	BMP2	181	P12643
ITFKRLIRFVPSSLS	CPT2	186	P23786
RPSRSTRSSIFQISK	RGS7BP	11	Q6MZT1
RLSESQLSFRRSPTK	RBM14	616	Q96PK6
KSRAPQFTILARTSL	ODF3B	196	A8MYP8
FSVQELPTRKLRVSS	PCDHGB4	56	Q9UN71
AQRRSAVFLSFKSPI	L3MBTL3	666	Q96JM7
LILDSFLTPRKTISF	OR13C6P	81	Q8NH95
LILDSFLTPRKTISF	OR13C7	81	P0DN81
TFIKELRSRVFPSAD	KDM7A	121	Q6ZMT4
DSNIRLTTKSFRPFV	LBP	311	P18428
FNTPLSILDRSTRQK	nan	146	O00370
TFQARPLSADLTKLF	KIAA1671	501	Q9BY89
ISSLFPTRAENFSRK	NLRP8	431	Q86W28
RFNTTKVVSTFNLPL	ARRDC5	261	A6NEK1
VFPNKRSFILTRSTF	MGAM	601	O43451
TPEDFNLLKSSNFRR	HLCS	346	P50747
KSFLTLTQPDRALVR	PCNX3	251	Q9H6A9
RPFSRFSVDKLLSVF	OR4K14	261	Q8NGD5
DRFPITLLQTSLKFT	DNAH8	4001	Q96JB1
RTPSDFKALRTVSVL	GPR119	216	Q8TDV5
IFTSLARLPTSKRSL	NIPBL	1456	Q6KC79
FLRSIIKTTPSQFST	NIPBL	1726	Q6KC79
STLFVETSLRRPQDK	LONP1	776	P36776
STSAEPLSRSIFRKF	HS3ST3A1	11	Q9Y663
FSFRKSTPERRTVQV	PLCG2	31	P16885
FSVQELPTRKLRVSS	PCDHGB5	56	Q9Y5G0
TLLQPTVNKFSLRVF	HCN3	51	Q9P1Z3
SREPLSTFRKLSQIF	RGL3	366	Q3MIN7
SLAVARPFVSQKLRT	LTB4R	116	Q15722
EKTSFTFLRQELPVR	PDK2	46	Q15119
QRLIKRAPFSISAFS	PARP11	101	Q9NR21
NKFLSQLEITFRRDP	ABCE1	556	P61221
PFERLAFVLSSNSLK	KLHL13	236	Q9P2N7
QKLFPFSSRERRSFT	KCNB2	791	Q92953
FPFEASLLTSVARRK	DACT2	591	Q5SW24
SRFSPLFRQESSKIS	DOCK10	576	Q96BY6
EFVKQRRSIISPNFS	DUSP1	286	P28562
RLLGFEPFSQRKLST	GHSR	336	Q92847
LLIVGFTSRFKRQTS	CD1D	316	P15813
FLQRRSKFSRPEFIL	FRMPD2	301	Q68DX3
RTFSVIKIFPDLSSN	CC2D1A	641	Q6P1N0
PLRTITADTFRKLFR	EPO	156	P01588
LLAVTRPFISSKFSQ	BNIP2	256	Q12982
KFTSSSDIPVEFIRR	C3orf33	61	Q6P1S2
AFFKLTLSRSPLVSQ	MS4A14	206	Q96JA4
DNRLKLTFSPFQVLS	MAN2C1	1016	Q9NTJ4
LSPRTSNVRSTFFKD	FAM118B	111	Q9BPY3
FAFSSVLDTVLLRPK	CYLD	611	Q9NQC7
TLVSPFIDDNTRRKF	SEC14L1	446	Q92503
EINVTLKFTSRFIRP	CFAP47	1931	Q6ZTR5
LKFTSRFIRPAEASL	CFAP47	1936	Q6ZTR5
SLSTPERSFIFINSR	PMS1	251	P54277
ITLLKLATPARFSQT	CTRB1	121	P17538
SSFFTLSLQKPRLLL	C4A	11	P0C0L4
SSEVRLKRFTLQFLP	FAM126B	66	Q8IXS8
TPNITKLRTDLRFIA	UPF2	256	Q9HAU5
TFVLEPRSFLNKLSD	OSBPL5	391	Q9H0X9
DLRLVTIPSFFSKSA	OPN1SW	281	P03999
RTPFTTSQLLALERK	MSX2	146	P35548
AETIRSLRKSFASLF	SYN2	566	Q92777
EKRFTSRIPLVRSFA	SLC4A7	221	Q9Y6M7
SQLFIKELRSRTFPS	PHF2	86	O75151
RTILAVTRPFISSKF	PRUNE2	3006	Q8WUY3
FVTREFLRSLRKPFS	PPARD	311	Q03181
LLTISLNRTFPFSLQ	SOCS5	471	O75159
QLSVKDSFRDLFIPR	LIPI	26	Q6XZB0
RTPFTTAQLLALERK	MSX1	176	P28360
LSLIISDVFRFTVPK	ABCC6	316	O95255
FLSLRPEEKFSSRAV	RECQL4	1146	O94761
ARFTILPSESLNKFE	OVCH1	526	Q7RTY7
LAPLFRSVRSKLESF	PRR14	246	Q9BWN1
LAPNRRTKFVSFTSR	NGEF	596	Q8N5V2
RFRTVFAEKTLPFTL	STON2	676	Q8WXE9
RKSLAVDFVVPSLFR	ALK	51	Q9UM73
SDTTFKALRRQLPVT	CAPZA2	251	P47755
FLTREEVLSRKPAST	CCDC15	206	Q0P6D6
KTTRFGTLFERLNSL	C12orf40	216	Q86WS4
TITALFKTRFRLDFP	CLCN2	301	P51788
FRASQFRFLQTSPKI	PNMA5	241	Q96PV4
RRKINTFISFPLELD	USP51	606	Q70EK9
QTRFLSVTLVFPSKS	USP43	276	Q70EL4
SVTLVFPSKSQRFLR	USP43	281	Q70EL4
RSQPRSISESFLTVK	SSH2	31	Q76I76
SQPKLDRTSSFRQIL	SYNGAP1	146	Q96PV0
INRFRTIPLTFKDQF	SLC9A2	416	Q9UBY0
FRPIRKRLSSTSSEE	PROM2	806	Q8N271
SRPTFSITKEFILRF	TMEM232	41	C9JQI7
SRFSNIKTLDDLFPL	XRN1	841	Q8IZH2
LPKTVSFRINSEDFL	TMPRSS5	106	Q9H3S3
SERKFSLLQTLATFR	PHEX	181	P78562
AFVTFRATRKPLVQT	RNF121	116	Q9H920
NVRVSRSFPFVSKTL	CAD	1216	P27708
RKDDPRLSFTRQSFV	PRKDC	1806	P78527
LPLRATDFEVLSTKF	ZNF469	3011	Q96JG9
LLKFFRPENITVSSR	TRAPPC8	1286	Q9Y2L5
RQTIRSKRPALFSSS	GTF3C5	456	Q9Y5Q8
QLFSGRSDFRITTLK	WDR25	326	Q64LD2
RTSKLTTFVNFPLRD	USP2	511	O75604
LPSSKIRDVTFLFNE	UBR4	2041	Q5T4S7
QLFSLPSRTRSSKDL	ZFYVE16	651	Q7Z3T8
RSPTLSSQFKRSLEL	MYO7A	606	Q13402
FLPKTRRQIFSLLSA	MYO9A	411	B2RTY4
RRTSFSTSDVSKLLP	MYO9B	1351	Q13459